Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-01-11
2011-01-11
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S006500
Reexamination Certificate
active
07867981
ABSTRACT:
A method for treating fungal infections in a mammal that includes administering a therapeutically effective amount of a composition comprising substantially pure amphotericin B and a pharmaceutically acceptable carrier. Amphotericin BHP is associated with decreased toxicity in mammals and cells measured by cell viability and expression of cytokine markers. Thus, this method allows for reduced adverse reactions when using amphotericin B products.
REFERENCES:
patent: 3965090 (1976-06-01), Metzger
patent: 4035568 (1977-07-01), Schaffner et al.
patent: 4049898 (1977-09-01), Metzger
patent: 4054734 (1977-10-01), Metzger
patent: 4308375 (1981-12-01), Tang
patent: 4656288 (1987-04-01), Ono et al.
patent: 4663167 (1987-05-01), Lopez-Berestein et al.
patent: 4766046 (1988-08-01), Abra et al.
patent: 4902789 (1990-02-01), Michel et al.
patent: 5194266 (1993-03-01), Abra et al.
patent: 5616334 (1997-04-01), Janoff et al.
patent: 5965156 (1999-10-01), Proffitt et al.
patent: 6406713 (2002-06-01), Janoff et al.
Chapman Stanley W.
Cleary John D.
Kramer Robert E.
Myers, Jr. Richard S.
Peselev Elli
Stites & Harbison PLLC
University of Mississippi
LandOfFree
Compositions comprising highly purified amphotericin B does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising highly purified amphotericin B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising highly purified amphotericin B will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2646048